Monday, 17 January, 2022
TopicZydus Cadila

Topic: Zydus Cadila

Zydus Cadila’s Covid vaccine to be administered ‘only to adults as of now’

India's drug regulator cleared ZyCov-D for those aged 12 and above but Union Health Minister said his government does not want to make haste about administering Covid vaccines to children.

Zydus Cadila agrees to reduce Covid vaccine price but final deal yet to be reached: Sources

New Delhi: Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the...

2 months after vaccine approval, Covid shots for kids stuck on list of comorbidities, procedure

Zycov-D is the lone vaccine cleared for use in children in India. However, expert panel still thrashing out some issues to streamline the rollout for parents.

Modi govt drives hard bargain, ZyCov-D vaccine could cost Rs 275/dose or even less

The world’s first DNA vaccine for Covid manufactured by Gujarat-based Zydus Cadila is delivered using a special applicator costing Rs 30,000.

Vaccine makers upset over ‘differential pricing’ for ZyCov-D, and lack of clarity on exports

ZyCov-D has reportedly been priced by the company at Rs 1,900 for three doses while the others cost between Rs 205-215 per dose.

6 shots per patient, Rs 30,000 applicator gun complicate govt talks for ZyCov-D vaccine

World's first DNA vaccine, ZyCov-D is a 3-dose vaccine (administered in 2 injections each time) which requires a special needle-free applicator.

ZyCov-D price talks still on, but India begins training for use of needle-free applicator

First instalment of ZyCov-D, a three-dose Covid vaccine manufactured by Zydus Cadila, is expected next month. Vaccine doesn't require a needle injection to be administered.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Three-dose ZyCoV-D vaccine could be just two doses, says pharma firm Zydus Cadila

Zydus Cadilla says its test data shows that the vaccine appears to be just as effective in 2 doses as 3, and will be administered 28 days apart.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

On Camera


RBI proposes changes to valuation of bank investments, relaxing of investment class rules

A Reserve Bank of India discussion paper Friday suggested removing caps on the Held-To-Maturity class of securities, and allowing more types of instruments to be held within them.


A visual from the crash site in Tamil Nadu. | Photo: Twitter/ANI

CDS chopper crash was caused by weather change, leading to Controlled Flight Into Terrain: IAF

In Friday statement, IAF says tri-service Court of Inquiry ruled out mechanical failure, sabotage or negligence as cause of accident involving Mi-17 V5 helicopter last month.
Illustration by Soham Sen | ThePrint

Read my lips, I’m hurting, says Pakistan’s National Security Policy. What it means for India

The new policy is mostly chaff, but it reveals the most inward-looking Pakistan in 3 decades. It needs breathing space, and is realising loss of stature and friendship with US.